Richard N. Townsend's Securities Transactions in Lexeo Therapeutics, Inc.

Richard N. Townsend, an officer and director of Lexeo Therapeutics, Inc., reported the sale of 13,133 common shares on October 17, 2025, with an aggregate market value of $117,436.60. The shares were acquired through restricted stock vesting on October 15, 2025, as part of compensation. Additionally, Townsend sold 1,115 common shares on August 18, 2025, for $5,205.04. The sale on October 17, 2025, included an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution. The transactions were facilitated by Fidelity Brokerage Services LLC.